Telemedicine has been increasingly integrated into cardiac care, thus offering remote monitoring and consultation for patients with cardiovascular diseases. It promises to improve patient outcomes, especially in heart failure management, by enabling continuous monitoring of vital signs and facilitating remote patient-provider interactions. This technology has gained particular significance amidst the COVID-19 pandemic, thereby offering a safer alternative to in-person visits. This study assesses the effectiveness of telemedicine in the management of cardiac patients in Saudi Arabia, and reflects on its benefits, challenges, and overall impact on patient outcomes.
A retrospective cohort study was conducted to analyze patient records from Saudi healthcare facilities and compare health indicators before and after telemedicine implementation. The study involved cardiac patients who received telemedicine consultations and a control group who received traditional care. Statistical analyses, including the chi-square test, t-test, and ANOVA, were performed to identify differences between the groups while controlling for confounders.
There were no statistically significant differences between the telemedicine and control groups in terms of blood pressure (P = 0.72), heart rate (P = 0.65), readmission rate (P = 0.54), and medication adherence (P = 0.48). The patient satisfaction was slightly higher in the telemedicine group, although the difference was not statistically significant (mean satisfaction score of 3.01 vs. 2.83, P = 0.41).
The introduction of telemedicine did not significantly alter the cardiac patient outcomes compared with traditional in-person care in Saudi Arabia. Although telemedicine offers a promising alternative for patient management, its effectiveness may vary based on the individual patient's needs and specific health indicators. Further research is necessary to explore its full potential and to optimize its application in cardiac care.
Citation: Abdulah Saeed, Alhanouf AlQahtani, Abdullah AlShafea, Abdrahman Bin Saeed, Meteb Albraik. The impact of telemedicine on cardiac patient outcomes: A study in Saudi Arabian hospitals[J]. AIMS Medical Science, 2024, 11(4): 439-451. doi: 10.3934/medsci.2024030
Telemedicine has been increasingly integrated into cardiac care, thus offering remote monitoring and consultation for patients with cardiovascular diseases. It promises to improve patient outcomes, especially in heart failure management, by enabling continuous monitoring of vital signs and facilitating remote patient-provider interactions. This technology has gained particular significance amidst the COVID-19 pandemic, thereby offering a safer alternative to in-person visits. This study assesses the effectiveness of telemedicine in the management of cardiac patients in Saudi Arabia, and reflects on its benefits, challenges, and overall impact on patient outcomes.
A retrospective cohort study was conducted to analyze patient records from Saudi healthcare facilities and compare health indicators before and after telemedicine implementation. The study involved cardiac patients who received telemedicine consultations and a control group who received traditional care. Statistical analyses, including the chi-square test, t-test, and ANOVA, were performed to identify differences between the groups while controlling for confounders.
There were no statistically significant differences between the telemedicine and control groups in terms of blood pressure (P = 0.72), heart rate (P = 0.65), readmission rate (P = 0.54), and medication adherence (P = 0.48). The patient satisfaction was slightly higher in the telemedicine group, although the difference was not statistically significant (mean satisfaction score of 3.01 vs. 2.83, P = 0.41).
The introduction of telemedicine did not significantly alter the cardiac patient outcomes compared with traditional in-person care in Saudi Arabia. Although telemedicine offers a promising alternative for patient management, its effectiveness may vary based on the individual patient's needs and specific health indicators. Further research is necessary to explore its full potential and to optimize its application in cardiac care.
[1] |
Imberti JF, Tosetti A, Mei DA, et al. (2021) Remote monitoring and telemedicine in heart failure: implementation and benefits. Curr Cardiol Rep 23: 1-11. https://doi.org/10.1007/s11886-021-01487-2 ![]() |
[2] |
Kuan PX, Chan WK, Ying DKF, et al. (2022) Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis. Lancet Digit Health 4: e676-e691. https://doi.org/10.1016/S2589-7500(22)00124-8 ![]() |
[3] |
Ghilencea LN, Chiru MR, Stolcova M, et al. (2022) Telemedicine: benefits for cardiovascular patients in the COVID-19 era. Front Cardiovasc Med 9: 868635. https://doi.org/10.3389/fcvm.2022.868635 ![]() |
[4] |
Takahashi EA, Schwamm LH, Adeoye OM, et al. (2022) An overview of Telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association. Circulation 146: e558-e568. https://doi.org/10.1161/cir.0000000000001107 ![]() |
[5] | Hawayek J, Postal S, Rissmiller S (2022) How health plan providers and telehealth partnerships advance care & scaled adoption: panel session. Telehealth Med Today . https://doi.org/10.30953/tmt.v7.352 |
[6] | National Diagnostic Imaging, Telecardiology, Remote Cardiology, Mobile EKG, Cardiac Imaging Reporting, ECG (EKG) Interpretations And Echo Reading Services. Beachwood National Diagnostic Imaging, 2022. Available from: https://www.ndximaging.com/subspeciality-interpretations/telecardiology-and-remote-cardiology-services |
[7] |
Soliman AM (2020) Telemedicine in the cardiovascular world: ready for the future?. Methodist Debakey Cardiovasc J 16: 283-290. https://doi.org/10.14797/mdcj-16-4-283 ![]() |
[8] | Dimitri DS, Pourriahi M, Sharma S, et al. (2021) Remote patient monitoring to improve outcomes in heart failure. J Cardiol Clin Res 9: 1171. |
[9] | Morris G (2023) Pros and Cons of cardiac remote monitoring. NurseJournal . Available from: https://nursejournal.org/articles/pros-and-cons-of-cardiac-remote-monitoring. |
[10] | American Heart Association, Telehealth is a valuable option in cardiovascular care, though challenges remain. Dallas American Heart Association, 2022. Available from: https://newsroom.heart.org/news/telehealth-is-a-valuable-option-in-cardiovascular-care-though-challenges-remain |
[11] |
Raju PK, Sistla PG (2022) Challenges in the implementation of telemedicine. J Indian Coll Cardiol 12: 178-183. https://doi.org/10.4103/jicc.jicc_22_21 ![]() |
[12] |
Singhal A, Riley JP, Cowie MR (2023) Benefits and challenges of telemedicine for heart failure consultations: a qualitative study. BMC Health Serv Res 23: 847. https://doi.org/10.1186/s12913-023-09872-z ![]() |
[13] |
Perk J, Graham I, De Backer G (2014) Prevention of cardiovascular disease: new guidelines, new tools, but challenges remain. Heart 100: 675-677. https://doi.org/10.1136/heartjnl-2014-305650 ![]() |
[14] |
Schwamm LH, Chumbler N, Brown E, et al. (2017) Recommendations for the implementation of telehealth in cardiovascular and stroke care: a policy statement from the American Heart Association. Circulation 135: e24-e44. https://doi.org/10.1161/CIR.0000000000000475 ![]() |
[15] |
Mermelstein HT, Wallack JJ (2008) Confidentiality in the age of HIPAA: a challenge for psychosomatic medicine. Psychosomatics 49: 97-103. https://doi.org/10.1176/appi.psy.49.2.97 ![]() |
[16] | Shah R (2023) 5 must-follow best practices for Telemedicine implementation in your care facility, . Available from: https://www.osplabs.com/insights/5-must-follow-best-practices-for-telemedicine-implementation-in-your-care-facility/ |
[17] |
Patel P, Dhindsa D, Eapen DJ, et al. (2021) Optimizing the potential for telehealth in cardiovascular care (in the era of COVID-19): time will tell. Am J Med 134: 945-951. https://doi.org/10.1016/j.amjmed.2021.03.007 ![]() |
[18] |
Albulushi A, Al Kindi DI, Moawwad N, et al. (2024) Digital health technologies in enhancing patient and caregiver engagement in heart failure management: opportunities and challenges. Int J Cardiol 408: 132116. https://doi.org/10.1016/j.ijcard.2024.132116 ![]() |